v3 Template
M

MicrobiotiX

Biotechnology ~10 employees
Founded
--
Employees (Est.)
~10
1 leaders known
Total Funding
$20.0B
Funding Rounds
1
Last Funding
2025-09-03

About MicrobiotiX

MicrobiotiX is dedicated to developing bacteriophage-based therapeutics targeting multidrug-resistant pathogens. The company aims to address global intractable diseases, particularly bacterial infections, through a comprehensive platform for drug discovery and development, including a bacteriophage library, in-silico modules, and a GMP-certified manufacturing facility.

Products & Services

Bacteriophage-based Therapies:Therapeutics targeting multidrug-resistant bacteria such as Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and Escherichia coli, using a library of 300 lytic bacteriophages.
CMO Services:Contract Manufacturing Organization services with a focus on GMP-certified facilities ensuring high-quality production and regulatory compliance.

Specialties

Bacteriophage-based therapeutics Multidrug-resistant pathogen treatment Phage and microbiome science GMP-certified manufacturing

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B 		A: 20000000000
MR: -
FA: 20 billion KRW
FAN: 20000000000 		D: 2025-09-03
FD: 2025-09-03 		3 investors
Series B Latest
2025-09-03
$20.0B
3 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Dongeun Yong

CEO

Recent News

MicrobiotiX Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~10 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro